HR and cancer: Focusing on TME-derived factors, our previous findings have demonstrated the impact of a combined stimulus representing three key arms of the tumor milieu of HR+/HER2− tumors—including hormonal, inflammatory and growth stimulating factors—on the pro-malignancy phenotype of the cancer cells.